Medtronic Acquires Mazor Robotics for $1.64B or $1.34B to Transform Spinal Technologies and Improve Outcomes

 Medtronic Acquires Mazor Robotics for $1.64B or $1.34B to Transform Spinal Technologies and Improve Outcomes

Medtronic Acquires Mazor Robotics for $1.64B or $1.34B to Transform Spinal Technologies and Improve Outcomes

Shots:

  • Medtronic will acquire Mazor’s American Depository Share (for $58.50) or Ordinary share (for $29.25 (104.80 ILS)) per share, making it total of ~$1.64B or ~$1.34B respectively. The acquisition is expected to close in Q3’ 25 Jan, 2019
  • The gain will obtain Mazor’s technology to build spine surgery platform including the Mazor X, the Renaissance Surgical-Guidance System for surgical planning, execution and confirmation
  • In 2016, Medtronic and Mazor entered into strategic and equity investment agreement and in Aug, 2017 Medtronic acquired worldwide rights for Mazor’s Mazor X system

Click here to read full press release/ article | Ref: Medtronic | Image: Aithority

Vartika Singh

Vartika Singh is a content writer who loves to write research articles and reports at PharmaShots. She has in-depth knowledge of the life sciences industry including the Pharma and Biotech sectors. Any articles written by her can be contacted at connect@pharmashots.com.

Related post